Company Filing History:
Years Active: 2010
Title: Thomas Jeff Clark: Innovator in Pharmaceutical Compositions
Introduction
Thomas Jeff Clark is a notable inventor based in Elon, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on diazabicyclic compounds. His research and inventions have the potential to impact various therapeutic applications.
Latest Patents
Thomas Jeff Clark holds 1 patent related to pharmaceutical compositions and methods for use. His patent focuses on diazabicyclic compounds, specifically N-aryl diazabicyclic compounds. Among the compounds of interest are 2-pyridinyl diazabicyclic compounds, including (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane. Other exemplary compounds include (1S,4S)-2-(5-(4-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, (1S,4S)-2-(5-(3-thienyl)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, (1S,4S)-2-(5-(4-fluorophenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, and (1S,4S)-2-(5-benzoyl-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane. The invention also encompasses prodrug derivatives of these compounds.
Career Highlights
Thomas Jeff Clark is associated with Targacept, Inc., where he continues to advance his research in pharmaceutical innovations. His work has contributed to the development of new therapeutic options that may benefit patients in need of effective treatments.
Collaborations
Throughout his career, Thomas has collaborated with notable colleagues, including Craig Harrison Miller and Gary Maurice Dull. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.
Conclusion
Thomas Jeff Clark is a distinguished inventor whose work in pharmaceutical compositions showcases his commitment to advancing medical science